Revenue
2019
2020
2021
2022
2023
2024
2025
2026
HEALTHEQUITY, INC. (HQY)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2019
2020
2021
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.20B | $999.6M | $861.7M | $756.6M | $733.6M | $532.0M | $287.2M | $229.5M | $178.4M | $126.8M | $87.9M | $62.0M | $46.1M |
| Gross profit | $913.1M | $777.3M | $622.6M | $491.9M | $424.8M | $415.3M | $325.9M | $181.2M | $134.9M | $106.4M | $72.6M | $48.0M | $32.8M | $24.1M |
| Research & development | $262.5M | $239.5M | $218.8M | $193.4M | $157.4M | $124.8M | $77.6M | $35.1M | $27.4M | $22.4M | $16.8M | $10.5M | $7.1M | $4.2M |
| Operating expenses | $590.7M | $614.9M | $504.9M | $482.9M | $449.0M | $381.3M | $248.9M | $103.5M | $80.5M | $65.1M | $46.5M | $31.1M | $21.3M | $17.0M |
| Operating income | $322.5M | $162.3M | $117.7M | $9.1M | −$24.2M | $34.0M | $77.0M | $77.7M | $54.4M | $41.2M | $26.1M | $16.9M | $11.5M | $7.1M |
| EBITDAderived | $477.1M | $324.8M | $270.8M | $170.3M | $113.0M | $149.9M | $132.4M | $95.9M | $70.4M | $54.4M | $34.7M | $22.8M | $15.8M | $10.5M |
| Net income | $215.2M | $96.7M | $55.7M | −$26.1M | −$44.3M | $8.8M | $39.7M | $73.9M | $47.4M | $26.4M | $16.6M | $10.2M | $1.2M | $11.2M |
| Basic EPSper diluted share | $2.50 | $1.11 | $0.65 | -$0.31 | -$0.53 | $0.12 | $0.59 | $1.20 | $0.79 | $0.45 | $0.29 | $0.39 | -$1.26 | $0.81 |
| Diluted EPSper diluted share | $2.46 | $1.09 | $0.64 | -$0.31 | -$0.53 | $0.12 | $0.58 | $1.17 | $0.77 | $0.44 | $0.28 | $0.21 | -$1.26 | $0.25 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026Form 4 · 10b5-1 | Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER | SellCommon Stock | 3.1K | $95.00 | $298.5K | 59.1K |
| May 28, 2026Form 4 · 10b5-1 | Wellborn Gayle FurgursonDirector | SellCommon Stock | 2.4K | $90.00 | $219.5K | 19.7K |
| May 28, 2026Form 4 · 10b5-1 | Ladd DelanoEVP, General Counsel | SellCommon Stock | 7.5K | $90.00 | $675.0K | 91.1K |
| Dec 19, 2025Form 4 · 10b5-1 | Ladd DelanoEVP, General Counsel | SellCommon Stock | 1.5K | $94.72 | $142.1K | 74.0K |
| Dec 18, 2025Form 4 | Rosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER | SellCommon Stock | 11.0K | $95.45 | $1.05M | 45.7K |